Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Heteroatom-substituted fatty acids have been observed to modulate the extension and desaturating of fatty acids, and to influence their distribution within phospholipids pools. 10-Thiastearic acid inhibits desaturation of radiolabeled stearate to oleate in rat hepatocytes and hepatoma cells by more than 80% at a concentration of 25 μM. This activity is associated with a hypolipidemic effect, making this 10-thiastearic acid a useful tool for evaluating new anti-obesity therapeutics.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 98.00 | |
10 mg | 35 days | $ 195.00 | |
50 mg | 35 days | $ 788.00 | |
100 mg | 35 days | $ 1,400.00 |
Description | Heteroatom-substituted fatty acids have been observed to modulate the extension and desaturating of fatty acids, and to influence their distribution within phospholipids pools. 10-Thiastearic acid inhibits desaturation of radiolabeled stearate to oleate in rat hepatocytes and hepatoma cells by more than 80% at a concentration of 25 μM. This activity is associated with a hypolipidemic effect, making this 10-thiastearic acid a useful tool for evaluating new anti-obesity therapeutics. |
Molecular Weight | 302.52 |
Formula | C17H34O2S |
CAS No. | 105099-89-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS (pH 7.2): 0.15 mg/mL
DMSO: 10 mg/mL
DMF: 10 mg/mL
Ethanol: 10 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
10-Thiastearic Acid 105099-89-6 10Thiastearic Acid 10 Thiastearic Acid inhibitor inhibit